Understanding the causes of Frontotemporal Dementia linked to specific gene mutations

Investigating Pathogenic Mechanisms of Frontotemporal Dementia Caused by Mutations in CHMP2B and TBK1

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-10749900

This study is looking into how certain gene changes related to Frontotemporal Dementia (FTD) affect brain cells, using models like fruit flies and mice, to help find new ways to understand and treat the disease for patients.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-10749900 on NIH RePORTER

What this research studies

This research investigates the underlying mechanisms of Frontotemporal Dementia (FTD) caused by mutations in the CHMP2B and TBK1 genes. By utilizing various experimental models, including fruit flies, mice, and human cells, the study aims to explore how these genetic mutations affect cellular processes related to degradation pathways in the brain. Patients may benefit from insights gained into the disease's progression and potential new therapeutic targets. The research focuses on understanding both common and rare genetic mutations associated with FTD.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with Frontotemporal Dementia, particularly those with known mutations in the CHMP2B or TBK1 genes.

Not a fit: Patients with Frontotemporal Dementia not linked to the CHMP2B or TBK1 mutations may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options for patients suffering from Frontotemporal Dementia and related conditions.

How similar studies have performed: Previous research has shown promise in understanding genetic contributions to neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Amyotrophic Lateral Sclerosis Motor Neuron DiseaseGehrig's DiseaseLou Gehrig Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.